B-Body® platform complements Twist’s antibody discovery offering enabling rapid, efficient and precise expression and discovery of complex bispecific antibody therapeutics Platform to power high-throughput characterization of bispecific antibodies to fuel AI-enabled and traditional drug discovery SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it has [...]

Partnership will deliver AI-guided end-to-end workflow to access challenging membrane protein targets To de-risk and shorten path to critical structural and biophysical insights that inform structure-based drug design Cambridge, UK, Boston MA, USA and Villigen, Switzerland -- Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery [...]

STOCKHOLM, Sweden -- CubaseBio, a biotechnology company founded by pioneers in spatial biology, today announced it has secured €5.9 million in blended financing. The funding comprises a €2 million non-dilutive grant from the European Innovation Council (EIC) Transition program and €3.9 million in private capital and convertibles from Voima Ventures, Nordic Science Investments (NSI), Illumina Ventures, Almi invest, Life Science Invest and [...]

SOMERVILLE, Mass. -- Matterworks, Inc., a frontier AI company providing predictive biology tools that accelerate discovery, development and manufacturing across life science applications, announced that Paul Stone has joined the company as Chief Financial Officer and Head of Corporate Development. Mr. Stone is a life sciences executive with over twenty-eight years of experience and leadership [...]

Ella benchtop instrument is now CE-IVD marked and available for sale in the EU Enables diagnostic assay developers to leverage a simplified platform that delivers speed and reproducible results with minimal hands-on time Provides confidence for use in clinical trials and in-house test development    MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science [...]

Amsbio has introduced an expanded range of Skeletal Muscle Differentiation Kits designed to reproducibly convert pluripotent or embryonic stem cells into myoblasts with high regenerative potential. Using a simple 3-step process of media changes and cell passaging – these advanced kits can typically achieve 70% MF20-positive myotubes. The highly efficient protocol employed by the kit does not require genetic intervention or cell sorting, [...]

Port Harcourt, Rivers State - MyAfroDNA, an African biotechnology company focused on advancing genomics research and innovation on the African continent, has announced the acquisition and deployment of the MGI CycloneSEQ™ genome sequencer, becoming the first facility in West Africa to deploy this advanced, portable sequencing platform. CycloneSEQ is a cost-efficient long-read sequencing platform suitable [...]

HONG KONG -- Omics Empower, a global life science service provider specializing in single-cell sequencing and spatial transcriptomics, announced that Xenium™ In Situ Spatial Transcriptomics services are now available at its Hong Kong Science Park laboratory. Since the launch of the Hong Kong laboratory in July 2025, Omics Empower has supported research teams with local single-cell [...]

BOTHELL, Wash. —BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces it has entered into a multi-year supply agreement with Qkine Limited under which BioLife will distribute certain ctokine and growth factor products manufactured by Qkine for use in cell and gene [...]

— Open Aperture provides no-cost access to TfR1 CapX, a leading central nervous system-targeting AAV capsid — NEW YORK, NY – Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today announced the launch of Open Aperture, a material transfer agreement program that provides qualified academic researchers with access to [...]